Ask Dr. Hersh
LASIk Self-Evaluation Test
LASIk Self-Evaluation Test
Hear From Our Patients LASIK
"Dr. Hersh and his staff were excellent. I would recommend the Cornea and Laser Eye Institute to anyone."
Luke Petitgout, Pro Athlete
New York Giants Football
Hear From Our Patients LASIK
LASIK Laser Eye Surgery New Jersey
The Most Advanced LASIK Technology
Dr. David Chu
Dr. Chu received his Bachelor's degree from Bowdoin College. He is a graduate of New York University School of Medicine and completed his ophthalmology residency at New York Medical College. Then he completed a fellowship in Ccular Inflammatory Disease and Uveitis at the Massachusetts Eye and Ear infirmary of Harvard Medical School.
Currently, he is an Assistant Professor at the Department of Ophthalmology at the UMDNJ - New Jersey Medical School. Dr. Chu specializes in corneal diseases and surgery with particular interest in inflammatory and immunologic conditions. His research interests include corneal wound healing, surgical and non-surgical therapies of various ocular inflammatory diseases, and novel techniques of corneal imaging.
At the Cornea and Laser Eye Institute, Dr. Chu cares for patients with cornea problems and difficult to treat ocular conditions, including uveitis, scleritis and ocular pemphigoid. He has extensive experience with the use of chemotherapeutic agents in the management of ocular inflammatory diseases. In addition, he has special interest in new surgical procedures such as amniotic membrane transplantation and state-of-the art corneal transplantation procedures including Intralase enabled laser corneal therapeutic and corneal transplant procedures (IEK), DSAEK, and anterior partial thickness corneal transplantation techniques.
Dr. Chu is also involved in a number of clinical research studies designed to evaluate the safety and efficacy of new drugs and techniques in the treatment of corneal and ocular inflammatory disorders. He is team ophthalmologist for the NY Jets.
CURRENT POSITIONS
Hackensack University Medical Center 03/2002-present
Department of Ophthalmology
Courtesy Staff Associate
East Orange Veterans Affairs Medical Center 09/2001-present
Department of Ophthalmology
Attending Physician
UMDNJ-New Jersey Medical School 08/2001-present
Department of Ophthalmology
Attending Physician; Assistant Professor
University Ophthalmology Consultants 8/2001-present
90 Bergen Street, Suite 6100
Newark, NJ 07103-2499
Private Practice
MEMBERSHIPS
- American Board of Ophthalmology
- American Academy of Ophthalmology
- American Medical Association
AWARDS AND HONORS
- "HIV positive patients with intracorneal precipitates between Descemet's membrane and endothelium" AAO-PAAO, Joint Meeting, October 24, 1999, 2nd Place Award- Select Free Papers at the Pan American Congress of Ophthalmology.
EXPERIENCE:
- Fibrogenesis in ocular surface diseases
- Immunomodulation in ocular inflammatory diseases
- Treatment of corneal neovascularization
- Teaches and lectures locally and nationally
BIBLIOGRAPHY
ARTICLES
Chu DS, Zaidman GW, Meisler D, Lowder C, Jacobs D, Rapuano C, Green GJ. "HIV positive patients with intracorneal precipitates between Descemet's membrane and endothelium." Ophthalmology 2001 Oct;108(10):1853-7.
Llinás R, Sugimori M, Chu D, Morita M, Blasi J, Herreros J, Jahn R, Marsal J. "Transmission at the squid giant synapse was blocked by tetanus toxin by affecting synaptobrevin, a vesicle-bound protein." Journal of Physiology 1994; 477(Pt 1):129-133.
Brady ST, Sugimori M, Leopold PL, Lin JW, Chu DS, Llinás R. "Activity-dependent inhibition of neurotransmitter release by brefeldin A." Biological Bulletin 1993; 185:299.
ABSTRACTS
Chu DS, Razzaque MS, Ahmed AR, Foster CS. "Localization of collagen IV, SPARC and tenascin in conjunctiva in ocular cicatricial pemphegoid" Invest Ophthalmol Vis Sci (Suppl) 2001; 42(4):S467.Razzaque MS, Chu DS, Foster CS, Ahmed AR. "Conjunctival expression of collagens and collagen-binding heat shock protein 47 in ocular cicatricial pemphegoid." Invest Ophthalmol Vis Sci (Suppl) 2001; 42(4):S521.
